Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter.

Varrin-Doyer M, Spencer CM, Schulze-Topphoff U, Nelson PA, Stroud RM, Cree BA, Zamvil SS. · 2012

Read Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter. by Varrin-Doyer M, Spencer CM, Schulze-Topphoff U, Nelson PA, Stroud RM, Cree BA, Zamvil SS. (2012) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3405197.txt.

Introduction

Varrin-Doyer and co-workers characterized in 2012 the T cells that attack a water channel in neuromyelitis optica, a disabling disease of the optic nerve and spinal cord. Patients make antibodies against the channel, called aquaporin 4, and such antibodies need T cell help. The team compared blood T cells from patients and healthy controls.

Patient T cells multiplied more strongly in response to the channel, especially to one standout stretch of it. That stretch closely resembles part of a transport protein from a common gut bacterium, and patient cells answered the bacterial piece too, a case of mistaken identity. The responding cells leaned toward the inflammatory Th17 style. The findings open fresh routes into how this disease begins.

Catalog record

CREATORVarrin-Doyer M, Spencer CM, Schulze-Topphoff U, Nelson PA, Stroud RM, Cree BA, Zamvil SS.
YEAR2012
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3405197

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Aquaporin 4-Specific T Cells in Neuromyelitis Optica Exhibit a Th17 Bias and Recognize Clostridium ABC Transporter By Michel Varrin-Doyer, Collin M Spencer, Ulf Schulze-Topphoff, Patricia A Nelson, Robert M Stroud, Bruce A C Cree, Scott S Zamvil Published in: Annals of Neurology DOI: 10.1002/ana.23651 ABSTRACT Abstract Objective Aquaporin 4 (AQP4)-specific autoantibodies in neuromyelitis optica (NMO) are immunoglobulin (Ig)G1, a T cell-dependent Ig subclass, indicating that AQP4-specific T cells participate in NMO pathogenesis. Our goal was to identify and characterize AQP4-specific T cells in NMO patients and healthy controls (HC). Methods Peripheral blood T cells from NMO patients and HC were examined for recognition of AQP4 and production of proinflammatory cytokines. Monocytes were evaluated for production of T cell-polarizing cytokines and expression of costimulatory molecules. Results T cells from NMO patients and HC proliferated to intact AQP4 or AQP4 peptides (p11–30, p21–40, p61–80, p131–150, p156–170, p211–230, and p261–280). T cells from NMO patients demonstrated greater proliferation to AQP4 than those from HC, and responded most vigorously to p61–80, a naturally processed immunodominant determinant of intact AQP4. T cells were CD4+, and corresponding to association of NMO with human leukocyte antigen (HLA)-DRB1*0301 and DRB3, AQP4 p61–80-specific T cells were HLA-DR restricted. The T-cell epitope within AQP4 p61–80 was mapped to 63–76, which contains 10 residues with 90% homology to a sequence within Clostridium perfringens adenosine triphosphate-binding cassette (ABC) transporter permease. T cells from NMO patients proliferated to this homologous bacterial sequence, and cross-reactivity between it and self-AQP4 was observed, supporting molecular mimicry. In NMO, AQP4 p61–80-specific T cells exhibited Th17 polarization, and furthermore, monocytes produced more interleukin 6, a Th17-polarizing cytokine, and expressed elevated CD40 and CD80 costimulatory molecules, suggesting innate immunologic dysfunction. Interpretation AQP4-specific T-cell responses are amplified in NMO, exhibit a Th17 bias, and display cross-reactivity to a protein of an indigenous intestinal bacterium, providing new perspectives for investigating NMO pathogenesis. ANN NEUROL 2012; Neuromyelitis optica (NMO) is a rare, disabling, sometimes fatal, central nervous system (CNS) demyelinating disease characterized by severe attacks of optic neuritis and transverse myelitis.1 NMO is considered to be primarily a humoral autoimmune disease, as a majority of NMO patients develop autoantibodies (NMO immunoglobulin [Ig]G) against aquaporin 4 (AQP4),2 the predominant CNS water channel, which is abundantly expressed on astrocytes. AQP4-specific antibodies in NMO serum are IgG1, a subclass of mature IgG that requires help from T cells,3 indicating that AQP4-specific CD4+ T cells participate in the genesis of this adaptive humoral response. Passive transfer of AQP4-specific antibodies alone did not produce CNS pathology, but did promote development of NMO-like lesions in recipient animals when CNS inflammation was induced by myelin-specific T cells.4, 5 T cells are detected within active NMO lesions.6 Further, NMO lesions are characterized by an abundance of eosinophils and neutrophils, and elevated levels of IL-17 have been associated with NMO,7 suggesting involvement of Th17 cells. However, as no previous studies have identified or characterized proliferative AQP4-specific T cells in NMO patients, their potential role in NMO pathogenesis is largely unknown. In this report, we first identified peripheral blood T cells from NMO patients and healthy controls (HC) that proliferated in response to discrete AQP4 peptides or intact AQP4. T cells from NMO patients demonstrated greater proliferation to this autoantigen than those from HC, and responded most frequently to p61–80. After defining the p61–80 core T-cell determinant, residues 63–76, we conducted a homology search with known microbes. We discovered that AQP4 p63–76 contains strong homology to aa 204–217 of an adenosine triphosphate-binding cassette (ABC) transporter permease of Clostridium perfringens, a bacterial species that contains both commensal and pathogenic strains for humans. T cells from NMO patients responded to the homologous ABC transporter peptide and exhibited cross-reactivity between this foreign antigen and AQP4 p63–76, findings that support molecular mimicry. When compared to HC, AQP4 p61–80-specific T cells from NMO patients exhibited Th17 polarization. Monocytes from NMO patients produced significantly higher levels of the Th17-polarizing cytokine interleukin (IL)-6, suggesting that immunologic dysfunction in NMO may also include the innate immune compartment. Collectively, our findings establish that AQP4-specific proliferative T cells exist, and support a Th17 bias in the adaptive immune response in NMO. Our demonstration of T-cell molecular mimicry may stimulate further evaluation of the potential role of the Clostridium species in NMO pathogenesis. PATIENTS AND METHODS Patients Fifteen NMO patients (12 females and 3 males, aged 44.3 ± 13.8 years) fulfilling Mayo Clinic diagnostic criteria8 and 9 HC (5 females and 4 males, aged 40.8 ± 10.7 years) were recruited from the University of California at San Francisco (UCSF) Multiple Sclerosis Center. A majority of NMO patients had been treated with rituximab,9 and none had been treated with azathioprine, mycophenolate mofetil, cyclophosphamide, or other immunosuppressive medications. None of the patients had received steroids within 2 months preceding blood draws. Blood was collected by venipuncture. This study was approved by the UCSF Committee on Human Research (Protocol # 10-00650), and written informed consent was obtained from subjects prior to enrollment. T-Cell Proliferation Assays Peripheral blood mononuclear cells (PBMC) were isolated by density gradient centrifugation over Ficoll (Ficoll-Paque PLUS; GE Healthcare, Milwaukee, WI) according to the manufacturer's instructions. T-cell proliferation was evaluated by [3H]thymidine incorporation or 5,6-carboxylfluorescein diacetate succinimidyl ester (CFSE) dilution assays. In thymidine incorporation assays, PBMC were cultured with antigens in 96-well plates at either 1 × 105 cells (AQP4 pools, in at least 10 wells) or 5 × 105 cells (individual peptides, in duplicate) per well for 6 days. Cultures were then pulsed with [3H]thymidine and harvested 18 hours later. Positive wells were defined as having counts per minute (cpm) values greater than control cpm average values + 3 standard deviations or stimulation index (SI) >2. Alternatively, PBMC were stained with 0.5μM CFSE (Invitrogen, Carlsbad, CA), according to the manufacturer's instructions. Cells were cultured in the presence of antigens for 10 days. T-cell proliferation was assessed by flow cytometric evaluation of CFSE dilution. Proliferation was expressed as the cell division index (defined as the number of CFSElow T cells cultured with antigen/number of CFSElow T cells without antigen). In all cases, culture medium consisted of X-VIVO 15 (Lonza, Walkersville, MD) supplemented with penicillin (100U/ml) and streptomycin (0.1mg/ml). Antigens Peptides were synthesized by Genemed Synthesis (San Antonio, TX) with purity >95% by high-performance liquid chromatography analysis. Overlapping AQP4 20-mer peptides were offset by 10 amino acids (Supplementary Table). Peptides corresponding to certain hydrophobic AQP4 sequences were synthesized in overlapping 15-mer peptide pairs. Truncated peptides within the 61–80 region (p61–78 GTEKPLPVDMVLISLCFG; p61–76 GTEKPLPVDMVLISLC; p61–74 GTEKPLPVDMVLIS; p61–72 GTEKPLPVDMVL; p63–80 EKPLPVDMVLISLC FGLS; p65–80 PLPVDMVLISLCFGLS; p67–80 PVDMVL ISLCFGLS; p69–80 DMVLISLCFGLS), AQP4 p63–76 (EKPLPVDMVLISLC), and bacterial peptide ABC-transporter permease (TP) p204–217 (FIILPVSMVLISLV) were as quoted. Full-length recombinant human (rh) AQP4 (1–323) was expressed in Pichia pastoris and purified as described.10 Tetanus toxoid was obtained from List Biological Laboratories (Campbell, CA). Flow Cytometry Analysis Single-cell suspensions were incubated with human serum to prevent nonspecific antibody binding, then stained with antibodies against CD3, CD4, CD8, CD25, major histocompatibility complex (MHC) class II, CD40, CD80, and CD86 (eBioscience, San Diego, CA and BD Biosciences, Mississauga, ON, Canada). Intracellular cytokine production by CD4+ T cells and antigen-presenting cells (APC) was analyzed by monitoring the expression of interferon (IFN)-γ, IL-17, IL-6, IL-1β, and

Read the complete text